Genmab | GEN - Stock


Genmab reported DKK13M in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Agios Pharmaceuticals USD 35.09M 2.17M Mar/2026
Almirall EUR 178.13M 1.54M Dec/2025
Amarin USD 183.58M 12.32M Mar/2026
Amgen USD 6.19B 39M Mar/2026
argenx SE USD 473.53M 132.91M Dec/2025
AstraZeneca USD 6.57B 13M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Demant DKK 2.62B 78M Dec/2025
Exelixis USD 26.6M 4.92M Mar/2026
Fresenius Medical Care EUR 2.3B 162.24M Mar/2026
Genmab DKK 13M 1000K Jun/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GN Store Nord DKK 2.31B 62M Dec/2025
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Insmed USD 132.91M 841K Mar/2026
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.56B 52M Dec/2025
Novartis USD 6.29B 17M Mar/2026
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024